INTERCEPT Blood System for Plasma
Pathogen Inactivation Data: Parasites
The INTERCEPT Blood System for plasma has been shown to inactivate contaminating parasites. Various in vitro studies have demonstrated inhibition of parasite replication following photochemical treatment. The results of these studies are summarized below:
| Parasites Tested Using the INTERCEPT Blood System for Plasma | Extent of Inactivation* (log10 reduction) |
| Plasmodium falciparum** (malaria) | ≥6.9 |
| Trypanosoma cruzi (Chagas’ disease) | >5.0 |
| Babesia microti (babesiosis) | >5.3 |
| * “>” refers to inactivation below the limit of detection of the assay “≥” refers to inactivation at or below the limit of detection of the assay ** intracellular |
|
Technical Data Sheets section page 5 of 7 
©
Cerus Corporation. All Rights Reserved.
Use of the INTERCEPT Blood System in the United States is limited by Federal law to investigational use. If you are a resident of the U.S., please click here.
The information on this site is not country-specific, and may contain information that is outside the approved indications for the country in which you are located. The INTERCEPT Blood System is CE marked for use with platelets and plasma.
Website design by NetPilot Web Solutions
Use of the INTERCEPT Blood System in the United States is limited by Federal law to investigational use. If you are a resident of the U.S., please click here.
The information on this site is not country-specific, and may contain information that is outside the approved indications for the country in which you are located. The INTERCEPT Blood System is CE marked for use with platelets and plasma.
Website design by NetPilot Web Solutions